NPI: 1538120902 · PASCAGOULA, MS 39567 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/28/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/28/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 25,599 | $395K |
| 2019 | 22,753 | $374K |
| 2020 | 24,598 | $374K |
| 2021 | 20,323 | $392K |
| 2022 | 15,487 | $399K |
| 2023 | 10,664 | $449K |
| 2024 | 5,531 | $351K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 38,846 | 3,849 | $2.01M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 37,695 | 2,248 | $506K |
| 83970 | 2,219 | 1,933 | $57K | |
| A4657 | Syringe, with or without needle, each | 6,115 | 2,741 | $54K |
| J1756 | Injection, iron sucrose, 1 mg | 9,209 | 2,111 | $33K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 719 | 638 | $14K |
| 82728 | 1,445 | 1,233 | $12K | |
| 82108 | 642 | 579 | $12K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 18,154 | 1,773 | $9K |
| 83550 | 1,181 | 1,038 | $8K | |
| 83540 | 1,483 | 1,234 | $6K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 373 | 37 | $5K |
| 85041 | 2,258 | 2,035 | $4K | |
| 85048 | 2,246 | 2,026 | $4K | |
| 90674 | 76 | 75 | $1K | |
| 82947 | 108 | 80 | $252.20 | |
| 90747 | 35 | 31 | $140.75 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 767 | 373 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,276 | 869 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 108 | 102 | $0.00 |